References
Badesch DB, Tapson VF, McGoon MD, et al (2000) Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 132:425–434
McLaughin VV, Genthner DE, Panella MM, Rich S (1998) Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 338:273–277
Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296:1305–1309
Mermel LA (1997) Defining intravascular catheter-related infections: a plea for uniformity. Nutrition 13 (Suppl):2–4
Salar A, Carratala J, Fernandez-Sevilla A, Marin D, Granena A (1997) Pneumonia caused by Micrococcus species in a neutropenic patient with acute leukemia. Eur J Clin Microbiol Infect Dis 16:546–548
Eiff C von, Kuhn N, Herrmann M, Weber S, Peters G (1996) Micrococcus luteus as a cause of recurrent bacteremia. Pediatr Infect Dis J 15:711–713
Kiehn TE, Armstrong D (1990) Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis 9:869–872
Ehrensing ER, Stamm AM, Aaron MF, Bourge RC (1998) Micrococcal bacteremia in patients with primary pulmonary hypertension on epoprostenol. In: Program and Abstracts, 8th Annual Meeting of the Society for Healthcare Epidemiology of America. Abstract no. 94
Kloos WE, Tornabene TG, Schleifer KH (1974) Isolation and characterization of micrococci from human skin, including two new species: Micrococcus lylae and Micrococcus kristinae. Intern J Syst Bacteriol 24:79–101
Horn WA, Larson EL, McGinley KJ, Leyden JJ (1988) Microbial flora on the hands of health care personnel: differences in composition and antibacterial resistance. Infect Control Hosp Epidemiol 9:189–193
Acknowledgements
The authors would like to thank J. Klinger, MD, and N. Hill, MD, for their assistance in lending the medical records of the patients; D. Auld, MT, ASCP, for obtaining the microbiological records and bacterial isolates; and N. Burdick, RN, for sharing the data on catheter placements.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yap, R.L., Mermel, L.A. Micrococcus Infection in Patients Receiving Epoprostenol by Continuous Infusion. Eur J Clin Microbiol Infect Dis 22, 704–705 (2003). https://doi.org/10.1007/s10096-003-1024-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-003-1024-1